Introduction: Populations at risk for HIV infection—including gay, bisexual, and other men who have sex with men (GBM) and transgender/gender diverse people (TGD)—are at disproportionate risk for anal cancer. Most anal cancers are caused by human papillomavirus (HPV) and are preventable with HPV vaccination and screening. Engaging at-risk populations who are already receiving HIV preventive […]
HPV Decide: The development and evaluation of a comprehensive tool to facilitate informed HPV choices among adults aged 27 to 45
Background: The shared clinical decision-making recommendation for mid-adult HPV vaccination in the United States (i.e., CDC 2019) may be successfully facilitated using patient-facing decision aids. The purpose of this study was to design, develop, and field test the HPV Decide decision tool among the target patient population (unvaccinated adults aged 27 to 45) and healthcare […]
Read Time:
3 Min
Integrating HPV vaccination into HIV prevention
This research has a simple hypothesis: Federally qualified health centers (FQHCs) can increase uptake and reach of HPV vaccination by integrating and promoting HPV vaccination into ongoing HIV preventive care (e.g., PrEP care). My prior work in this area suggest that this isn’t routinely happening. This is research I presented during the 15th AACR Conference on The […]
Read Time:
1 Min